Precision Drilling
PDS
Lantheus
LNTH
eBay
EBAY
4
DexCom
DXCM
5
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 172.56%447M | 110.20%206M | 540.91%194M | -15.29%133M | -82.98%-86M | -63.39%164M | -44.94%98M | -119.13%-44M | 282.93%157M | -4,600.00%-47M |
Net income from continuing operations | 46.33%-512M | 106.73%7M | -124.55%-494M | 25.45%-123M | 121.08%98M | -53.62%-954M | 70.29%-104M | -685.71%-220M | -142.65%-165M | -165.71%-465M |
Operating gains losses | -167.29%-144M | -22.22%7M | -666.67%-17M | ---140M | -97.03%6M | 10,600.00%214M | 200.00%9M | 175.00%3M | --0 | 20,300.00%202M |
Depreciation and amortization | -6.66%743M | -5.76%180M | -5.00%190M | -10.24%184M | -5.50%189M | -6.57%796M | -6.83%191M | -9.50%200M | -4.21%205M | -5.66%200M |
Deferred tax | -333.33%-42M | 188.24%49M | -34.62%-35M | 1,300.00%108M | -555.56%-164M | -60.87%18M | -34.62%17M | -420.00%-26M | -550.00%-9M | 56.52%36M |
Other non cash items | -176.02%-168M | 56.36%-48M | -160.38%-64M | -196.92%-63M | -95.63%7M | -5.56%221M | -161.80%-110M | 341.67%106M | 490.91%65M | 661.90%160M |
Change In working capital | -9.01%-254M | -97.53%2M | 77.87%-27M | 266.67%5M | -23.81%-234M | -147.87%-233M | -25.69%81M | -913.33%-122M | 97.69%-3M | -114.77%-189M |
-Change in receivables | 5.05%-94M | ---- | ---- | ---- | ---- | -560.00%-99M | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | -167.41%-91M | ---- | ---- | ---- | ---- | 1,587.50%135M | ---- | ---- | ---- | ---- |
-Change in other current assets | -2.04%-100M | ---- | ---- | ---- | ---- | -716.67%-98M | ---- | ---- | ---- | ---- |
-Change in other current liabilities | 71.43%-2M | ---- | ---- | ---- | ---- | -250.00%-7M | ---- | ---- | ---- | ---- |
-Change in other working capital | 120.12%33M | 92.67%289M | 77.87%-27M | 266.67%5M | -23.81%-234M | -124.66%-164M | 15.38%150M | -913.33%-122M | 97.69%-3M | -114.77%-189M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 172.56%447M | 110.20%206M | 540.91%194M | -15.29%133M | -82.98%-86M | -63.39%164M | -44.94%98M | -119.13%-44M | 282.93%157M | -4,600.00%-47M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 64.30%-151M | 87.73%-27M | 75.00%-10M | 0.00%-73M | 54.44%-41M | 44.12%-423M | 48.11%-220M | 58.76%-40M | 37.07%-73M | 25.00%-90M |
Capital expenditure reported | 40.52%-254M | 86.82%-29M | -16.00%-58M | -10.53%-84M | -2.47%-83M | 40.45%-427M | 46.21%-220M | 42.53%-50M | 33.91%-76M | 23.58%-81M |
Net business purchase and sale | 266.67%5M | --0 | --0 | --5M | --0 | 92.86%-3M | --0 | 187.50%7M | --0 | 33.33%-10M |
Net other investing changes | 1,300.00%98M | --2M | 1,500.00%48M | 100.00%6M | 4,100.00%42M | 250.00%7M | --0 | 250.00%3M | 0.00%3M | 0.00%1M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 64.30%-151M | 87.73%-27M | 75.00%-10M | 0.00%-73M | 54.44%-41M | 44.12%-423M | 48.11%-220M | 58.76%-40M | 37.07%-73M | 25.00%-90M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -233.08%-350M | -112.30%-38M | -82.39%-259M | 2,080.00%99M | -250.50%-152M | 334.82%263M | 397.12%309M | -402.13%-142M | -150.00%-5M | 255.38%101M |
Net issuance payments of debt | -225.19%-333M | -108.74%-27M | -84.29%-258M | 2,675.00%103M | -249.50%-151M | 170.18%266M | 402.94%309M | -600.00%-140M | 95.65%-4M | 161.21%101M |
Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other financing activities | -466.67%-17M | ---11M | 50.00%-1M | ---4M | ---1M | 62.50%-3M | --0 | 33.33%-2M | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -233.08%-350M | -112.30%-38M | -82.39%-259M | 2,080.00%99M | -250.50%-152M | 334.82%263M | 397.12%309M | -402.13%-142M | -150.00%-5M | 255.38%101M |
Net cash flow | ||||||||||
Beginning cash position | 0.40%995M | -0.99%800M | -15.38%875M | -25.03%716M | 0.40%995M | -29.82%991M | -39.75%808M | -10.94%1.03B | -22.10%955M | -29.82%991M |
Current changes in cash | -1,450.00%-54M | -24.60%141M | 66.81%-75M | 101.27%159M | -675.00%-279M | 100.95%4M | 153.43%187M | -225.56%-226M | 221.54%79M | 80.65%-36M |
End cash Position | -5.43%941M | -5.43%941M | -0.99%800M | -15.38%875M | -25.03%716M | 0.40%995M | 0.40%995M | -39.75%808M | -10.94%1.03B | -22.10%955M |
Free cash flow | 173.38%193M | 245.08%177M | 244.68%136M | -39.51%49M | -32.03%-169M | 2.23%-263M | 47.19%-122M | -165.73%-94M | 209.46%81M | -19.63%-128M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |